New Delhi , Jan. 13 : With recent government notification to bring stents under the country’s drug price control order, the prices of the life saving device would be regulated and capped by the National Pharmaceutical Pricing Authority . [NK Business] In view of the latest notification and its wider implications on healthcare technology providers, Healthcare Federation of India has suggested that the government needs to form a Health Technology Assessment Board for standardising and regulating the stent quality in India.